𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The influence of betahistine on the dynamics of the cutaneous hypersensitivity reaction in patients with grass pollen allergy

✍ Scribed by J.R. Snyman; De K. Sommers; M. van Wyk; M.D. Gregorowski


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
638 KB
Volume
30
Category
Article
ISSN
0162-3109

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effect of longterm cetirizine treatment
✍ J. R. Snyman; K. Sommers; M. Wyk; D. J. Lizamore πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 483 KB

In short-term studies cetirizine effectively reduces the early and late phases of the cutaneous hypersensitivity reaction. The aim of this study was to determine its long-term effects on both the vascular and cellular components of the reaction. The skin blister technique was used to collect inflam

Influence of histamine receptor antagoni
✍ J. R. Snyman; K. Sommers; M. D. Gregorowski πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 520 KB

The biphasic cutaneous hypersensitivity response elicited by intradermal administration of S. haematobium antigen to patients with schistosomiasis may be used as a model for drug effects on cell dynamics. As the effects of H1- and H2-blockade, and the possible involvement of H3-receptors, have not b

Effect of cetirizine, ketotifen and chlo
✍ J. R. Snyman; K. Sommers; M. D. Gregorowski; H. Boraine πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 442 KB

Allergic cutaneous challenge causes mast cell and basophil mediator release which recruit inflammatory cells to the site of antigen administration. This secondary cell infiltration and mediator release is responsible for the changes seen during the late phase of allergic diseases. In this randomised

A correlation of DNCB-induced delayed cu
✍ Thomas J. Cunningham; Dennis Daut; Patricia E. Wolfgang; Mary Mellyn; Susan Maci πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 538 KB

Delayed cutaneous hypersensitivity reactions to DNCB were performed before therapy i n 84 patients with recurrent breast cancer. Following sensitization, a lW+g challenge dose was graded as a strong, weak, or negative reaction. Thirty six patients were rechallenged 2 6 months with 100 +g of DNCB. Pa